Peripheral metabolic dysfunction is associated with cognitive frailty in a mouse model of type 2 diabetes.

IF 3.8 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Maria Teresa Venuti, Federico Brandalise, Mattia Cappelletti, Attilio F Speciani, Michela C Speciani, Erica Cecilia Priori, Francesca Giammello, Elisa Roda, Paola Rossi, Daniela Ratto
{"title":"Peripheral metabolic dysfunction is associated with cognitive frailty in a mouse model of type 2 diabetes.","authors":"Maria Teresa Venuti, Federico Brandalise, Mattia Cappelletti, Attilio F Speciani, Michela C Speciani, Erica Cecilia Priori, Francesca Giammello, Elisa Roda, Paola Rossi, Daniela Ratto","doi":"10.1007/s11011-026-01956-z","DOIUrl":null,"url":null,"abstract":"<p><p>Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder increasingly associated with cognitive impairment and neurodegeneration. Peripheral metabolic dysfunction, particularly insulin resistance and glycation stress, represents a critical link between diabetes and brain pathology. This study investigated the relationship between metabolic alterations and cognitive frailty using a murine T2DM model induced by a high-fat diet (HFD) combined with low-dose streptozotocin (STZ). Male C57BL/6J mice were longitudinally followed from adulthood to senescence and subjected to HFD alone or HFD plus STZ. Metabolic parameters, including fasting glycemia, oral glucose tolerance, insulin resistance (HOMA-IR), glycated albumin (GA), and methylglyoxal (MGO), were assessed over time. Cognitive function was evaluated using spontaneous behavioral tests of recognition memory (Novel Object Recognition, Object Location, and Y-maze), integrated into a cognitive frailty index. Post-mortem histological and immunohistochemical analyses were performed on pancreatic and hippocampal tissues. While HFD alone induced mild alterations, HFD/STZ mice developed a stable diabetic phenotype with severe hyperglycemia, pancreatic β-cell damage, elevated HOMA-IR, and increased GA and MGO levels. Notably, HFD/STZ mice exhibited a marked decline in recognition memory, affecting both knowledge and remembering components. At the central level, diabetic mice showed hippocampal cytoarchitectural alterations, increased tau hyperphosphorylation, and amyloid accumulation. Crucially, both insulin resistance and glycation stress (GA) directly correlated with recognition memory deficits. These findings demonstrate that peripheral metabolic dysfunction, i.e. insulin resistance and advanced glycation, directly correlates with hippocampal pathology and cognitive decline, supporting the translational relevance of the HFD/STZ model for diabetes-related cognitive frailty.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"41 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13498501/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-026-01956-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder increasingly associated with cognitive impairment and neurodegeneration. Peripheral metabolic dysfunction, particularly insulin resistance and glycation stress, represents a critical link between diabetes and brain pathology. This study investigated the relationship between metabolic alterations and cognitive frailty using a murine T2DM model induced by a high-fat diet (HFD) combined with low-dose streptozotocin (STZ). Male C57BL/6J mice were longitudinally followed from adulthood to senescence and subjected to HFD alone or HFD plus STZ. Metabolic parameters, including fasting glycemia, oral glucose tolerance, insulin resistance (HOMA-IR), glycated albumin (GA), and methylglyoxal (MGO), were assessed over time. Cognitive function was evaluated using spontaneous behavioral tests of recognition memory (Novel Object Recognition, Object Location, and Y-maze), integrated into a cognitive frailty index. Post-mortem histological and immunohistochemical analyses were performed on pancreatic and hippocampal tissues. While HFD alone induced mild alterations, HFD/STZ mice developed a stable diabetic phenotype with severe hyperglycemia, pancreatic β-cell damage, elevated HOMA-IR, and increased GA and MGO levels. Notably, HFD/STZ mice exhibited a marked decline in recognition memory, affecting both knowledge and remembering components. At the central level, diabetic mice showed hippocampal cytoarchitectural alterations, increased tau hyperphosphorylation, and amyloid accumulation. Crucially, both insulin resistance and glycation stress (GA) directly correlated with recognition memory deficits. These findings demonstrate that peripheral metabolic dysfunction, i.e. insulin resistance and advanced glycation, directly correlates with hippocampal pathology and cognitive decline, supporting the translational relevance of the HFD/STZ model for diabetes-related cognitive frailty.

外周代谢功能障碍与2型糖尿病小鼠模型的认知衰弱有关。
2型糖尿病(T2DM)是一种慢性代谢性疾病,与认知功能障碍和神经退行性变的关系日益密切。外周代谢功能障碍,特别是胰岛素抵抗和糖基化应激,是糖尿病和脑病理之间的关键联系。本研究采用高脂肪饮食(HFD)联合低剂量链脲佐菌素(STZ)诱导的小鼠T2DM模型,探讨代谢改变与认知衰弱之间的关系。对雄性C57BL/6J小鼠进行从成年到衰老的纵向随访,分别给予HFD或HFD加STZ。代谢参数,包括空腹血糖、口服葡萄糖耐量、胰岛素抵抗(HOMA-IR)、糖化白蛋白(GA)和甲基乙二醛(MGO),随时间进行评估。认知功能评估采用自发行为测试的识别记忆(新物体识别,物体定位,和y迷宫),整合到认知脆弱指数。死后对胰腺和海马组织进行组织学和免疫组织化学分析。虽然HFD单独诱导轻度改变,但HFD/STZ小鼠表现出稳定的糖尿病表型,伴有严重的高血糖、胰腺β细胞损伤、HOMA-IR升高、GA和MGO水平升高。值得注意的是,HFD/STZ小鼠在识别记忆方面表现出明显的下降,影响了知识和记忆成分。在中枢水平,糖尿病小鼠表现出海马细胞结构改变,tau过度磷酸化增加和淀粉样蛋白积累。至关重要的是,胰岛素抵抗和糖基化应激(GA)都与识别记忆缺陷直接相关。这些发现表明,外周代谢功能障碍,即胰岛素抵抗和晚期糖基化,与海马病理和认知能力下降直接相关,支持HFD/STZ模型在糖尿病相关认知衰弱中的翻译相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolic brain disease
Metabolic brain disease 医学-内分泌学与代谢
CiteScore
5.90
自引率
5.60%
发文量
248
审稿时长
6-12 weeks
期刊介绍: Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书